Case Reports
doi: 10.1097/JTO.0b013e31802bffb0.
Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure
- PMID: 17410020
- DOI: 10.1097/JTO.0b013e31802bffb0
Item in Clipboard
Case Reports
Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure
J Thorac Oncol.
2007 Jan.
Free article
No abstract available
Similar articles
-
Erlotinib effective against refractory bronchorrhea from advanced non-small cell lung cancer.J Thorac Oncol. 2007 Sep;2(9):881-2. doi: 10.1097/JTO.0b013e3181461999. J Thorac Oncol. 2007. PMID: 17805071 No abstract available.
-
Lung cancer response to gefitinib, then erlotinib, then gefitinib again.J Thorac Oncol. 2008 Sep;3(9):1077-8. doi: 10.1097/JTO.0b013e318183afb0. J Thorac Oncol. 2008. PMID: 18758318 No abstract available.
-
Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer.Expert Rev Anticancer Ther. 2011 Jul;11(7):991-7. doi: 10.1586/era.11.74. Expert Rev Anticancer Ther. 2011. PMID: 21806322 Review.
-
Two generations of light/never-smokers with advanced adenocarcinoma of the lung with durable responses to erlotinib.J Thorac Oncol. 2012 Jul;7(7):1200-1. doi: 10.1097/JTO.0b013e318250ed89. J Thorac Oncol. 2012. PMID: 22706608 No abstract available.
-
The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.Oncologist. 2005 Aug;10(7):467-70. doi: 10.1634/theoncologist.10-7-467. Oncologist. 2005. PMID: 16079313 Review. No abstract available.
Cited by
-
Drug-Drug Interactions, Safety, and Pharmacokinetics of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer.J Adv Pract Oncol. 2018 Mar;9(2):189-200. Epub 2018 Mar 1. J Adv Pract Oncol. 2018. PMID: 30588353 Free PMC article. Review.
-
Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure.Curr Drug Metab. 2019;20(5):361-376. doi: 10.2174/1389200220666190402143125. Curr Drug Metab. 2019. PMID: 30947665 Free PMC article. Review.
-
Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancer.Curr Gerontol Geriatr Res. 2010;2010:348174. doi: 10.1155/2010/348174. Epub 2010 Jun 20. Curr Gerontol Geriatr Res. 2010. PMID: 20672050 Free PMC article.
-
Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation.BMJ Case Rep. 2014 Jul 23;2014:bcr2014204809. doi: 10.1136/bcr-2014-204809. BMJ Case Rep. 2014. PMID: 25056302 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
